http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2372077-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f11ac5ada799060f8c2e97b1ee47b80d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-453 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-453 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate | 2010-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e874095d02b2ad5c8ad2c852a2e5836 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eee61e6469c75d2a947c1268b8f2d9af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f49f7c77b5babcb4f03e623c8aa8fa2 |
| publicationDate | 2012-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2372077-A1 |
| titleOfInvention | USE OF RAPAMYCIN FOR THE TREATMENT OF COGNITIVE DEFICITS ASSOCIATED WITH DOWN SYNDROME. |
| abstract | Use of rapamycin for the treatment ofncognitive deficits associated with Down syndrome.n n n The present invention relates to the use of ancomposition comprising an mTOR protein inhibitor, wherenthat inhibitor is selected from rapamycin, temsirolimus,neverolimus or deforolimus. In addition the present invention relates tonuse of these inhibitors, and preferably rapamycin, for thenmanufacture of a drug for the treatment of deficitnCognitive associated with Down syndrome. |
| priorityDate | 2010-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 136.